Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Creative Biosciences
company
About
Creative Biosciences is a biomedical technology company.
- 51 - 100
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥560M
- Industries
- Biopharma,Biotechnology,Health Care
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥1.16B
Creative Biosciences has raised a total of
¥1.16B
in funding over 2 rounds. Their latest funding was raised on
Oct 14, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 14, 2021 | Series D | ¥560M | 1 | — | — | Detail |
| Sep 27, 2020 | Series C | ¥600M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
Creative Biosciences is funded by 4 investors.
Agricultural Bank of China
and Shengyu Touzi
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Agricultural Bank of China
|
— | Series D |
|
|
— | Series C |
Innovitalize Capital
|
— | Series C |
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
